» Articles » PMID: 9766644

RIZ1, but Not the Alternative RIZ2 Product of the Same Gene, is Underexpressed in Breast Cancer, and Forced RIZ1 Expression Causes G2-M Cell Cycle Arrest And/or Apoptosis

Overview
Journal Cancer Res
Specialty Oncology
Date 1998 Oct 10
PMID 9766644
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

The retinoblastoma protein-interacting zinc finger gene RIZ maps to the distal short arm of human chromosome 1 (1p36), a region thought to harbor tumor suppressor genes for a variety of human cancers including breast cancer. The RIZ gene normally produces two protein products of different length, RIZ1 and RIZ2. RIZ2 is generated by an internal promoter and lacks an NH2-terminal motif of RIZ1, the PR domain conserved in a subfamily of zinc finger genes that function as negative regulators of tumorigenesis. We have here studied whether the RIZ gene may play a role in human neoplasia. We found that expression of RIZ1 is commonly decreased or at undetectable levels in breast cancer tissues and cell lines. Decreased RIZ1 expression was also found in other tumor types including neuroblastoma and lung cancer. Remarkably, RIZ2 is normally expressed in all cases examined, suggesting that the abnormality observed for RIZ1 is specific. Forced RIZ1 expression in breast cancer cells caused cell cycle arrest in G2-M and/or programmed cell death. These observations suggest an exclusive negative selection for RIZ1 but not RIZ2 in breast cancer and a role for RIZ1 in tumor suppression.

Citing Articles

Aberrant PRDM2 methylation as an early event in serrated lesions destined to evolve into microsatellite-instable colorectal cancers.

van Toledo D, Bleijenberg A, Venema A, de Wit M, van Eeden S, Meijer G J Pathol Clin Res. 2024; 10(2):e348.

PMID: 38380944 PMC: 10880511. DOI: 10.1002/cjp2.348.


Tumor-suppressive functions of protein lysine methyltransferases.

Aziz N, Hong Y, Kim H, Kim J, Cho J Exp Mol Med. 2023; 55(12):2475-2497.

PMID: 38036730 PMC: 10766653. DOI: 10.1038/s12276-023-01117-7.


Targeting Histone Modifications in Breast Cancer: A Precise Weapon on the Way.

Li W, Wu H, Sui S, Wang Q, Xu S, Pang D Front Cell Dev Biol. 2021; 9:736935.

PMID: 34595180 PMC: 8476812. DOI: 10.3389/fcell.2021.736935.


The duality of PRDM proteins: epigenetic and structural perspectives.

Di Tullio F, Schwarz M, Zorgati H, Mzoughi S, Guccione E FEBS J. 2021; 289(5):1256-1275.

PMID: 33774927 PMC: 8979648. DOI: 10.1111/febs.15844.


Searching for a Putative Mechanism of RIZ2 Tumor-Promoting Function in Cancer Models.

Rienzo M, Sorrentino A, Di Zazzo E, Di Donato M, Carafa V, Marino M Front Oncol. 2021; 10:583533.

PMID: 33585202 PMC: 7880127. DOI: 10.3389/fonc.2020.583533.